Granite Investment Partners’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-15,919
Closed -$5.18M 276
2024
Q1
$5.18M Sell
15,919
-363
-2% -$89.1K 0.2% 144
2023
Q4
$3.1M Sell
16,282
-3,179
-16% -$601K 0.12% 183
2023
Q3
$3.87M Sell
19,461
-1,141
-6% -$270K 0.16% 162
2023
Q2
$5.88M Sell
20,602
-6,205
-23% -$1.72M 0.23% 132
2023
Q1
$5.81M Buy
26,807
+281
+1% +$54.8K 0.24% 119
2022
Q4
$5.45M Sell
26,526
-115
-0.4% -$29.1K 0.23% 121
2022
Q3
$7.41M Buy
26,641
+158
+0.6% +$40.2K 0.32% 101
2022
Q2
$5.06M Buy
26,483
+1,501
+6% +$265K 0.21% 131
2022
Q1
$5.18M Buy
+24,982
New +$4.12M 0.18% 145

Other funds holding SWAV

Granite Investment Partners's SWAV Position: Q2 2024 in Review

Granite Investment Partners sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 15,919 shares — an estimated $5.18M sold.

Granite Investment Partners first reported a position in SWAV in Q1 2022 and held it in 9 quarters. The position peaked at $7.41M in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Granite Investment Partners reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Granite Investment Partners sold 15,919 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $5.18M.
  • Granite Investment Partners first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 9 quarters.
  • Granite Investment Partners's Shockwave Medical, Inc. Common Stock position peaked at $7.41M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Granite Investment Partners's 13F filing for Q2 2024, filed 12 Aug 2024.